Glenmark Pharmaceuticals has informed that it has attached media release on 03 February 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended?Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg’ which is self? explanatory
The above information is a part of company’s filings submitted to BSE.